Home » Topics » BioWorld Science

BioWorld Science
RSS

rSIFN-co demonstrates antitumor activity in phase I study in advanced solid tumors

Oct. 8, 2019

Dual inhibition of TGF-beta and AXL as novel therapeutic approach in metastatic CRC

Oct. 8, 2019

Mycobiome linked to pancreatic cancer

Oct. 8, 2019

Novel transgenerational mouse model of insulin resistance

Oct. 8, 2019

Kodiak begins phase II study of KSI-301 for wet AMD

Oct. 7, 2019

ReveraGen presents 18-month data on vamorolone in Duchenne muscular dystrophy

Oct. 7, 2019

Positive phase II data presented for lurbinectedin in malignant pleural mesothelioma

Oct. 7, 2019

GSK begins first-in-human study of rabies vaccine GSK-3903133A

Oct. 7, 2019

FDA approves Aklief cream for topical treatment of acne

Oct. 7, 2019

Main function of Parkinson's gene is in inflammation

Oct. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...